Paper2909288
Evaluation of the effect of furosemide on ultrafilterable platinum kinetics in patients treated with cis-diamminedichloroplatinum.
Dumas M and 6 others. Cancer Chemother Pharmacol, 1989. Cited by 16 papers, by iCite.
Cite this record
ConductScience Library. Evaluation of the effect of furosemide on ultrafilterable platinum kinetics in patients treated with cis-diamminedichloroplatinum. Papers, record 2909288. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2909288
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cisplatin | Major topic |
| Furosemide | Major topic |
| Platinum | Major topic |
| Humans | |
| Kidney | |
| Metabolic Clearance Rate | |
| Ultrafiltration |
Source PubMed
References18
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 498151 | Pharmacokinetics of non-protein-bound platinum species following administration of cis-dichlorodiammineplatinum(II). | Cancer Treat Rep | 1979 | https://conductscience.org/library/papers/498151 | PubMed |
| 2 | 856437 | High dose cis-platinum diammine dichloride: amelioration of renal toxicity by mannitol diuresis. | Cancer | 1977 | https://conductscience.org/library/papers/856437 | PubMed |
| 3 | 118952 | The effect of diuretic pre-treatment on clinical, morphological and ultrastructural cis-platinum induced nephrotoxicity. | Int J Radiat Oncol Biol Phys | 1979 | https://conductscience.org/library/papers/118952 | PubMed |
| 4 | 3542269 | Urinary beta 2-microglobulin: early indicator of high dose cisdiamminedichloroplatinum nephrotoxicity? Influence of furosemide. | Cancer Chemother Pharmacol | 1986 | https://conductscience.org/library/papers/3542269 | PubMed |
| 5 | 421210 | Effects of mannitol or furosemide diuresis on the nephrotoxicity and physiological disposition of cis-dichlorodiammineplatinum-(II) in rats. | Cancer Res | 1979 | https://conductscience.org/library/papers/421210 | PubMed |
| 6 | 6685336 | Mechanisms of renal excretion of cisdichlorodiamine platinum. | Res Commun Chem Pathol Pharmacol | 1983 | https://conductscience.org/library/papers/6685336 | PubMed |
| 7 | 844049 | Prevention of renal failure in rats receiving cis-diamminedichloroplatinum(II) by administration of furosemide. | Cancer Res | 1977 | https://conductscience.org/library/papers/844049 | PubMed |
| 8 | 6161715 | Pharmacokinetics and protein binding of cis-dichlorodiammine platinum (II) administered as a one hour or as a twenty hour infusion. | Cancer Chemother Pharmacol | 1980 | https://conductscience.org/library/papers/6161715 | PubMed |
| 9 | 6890406 | Cisplatin urinary pharmacokinetics and nephrotoxicity: a common circadian mechanism. | Cancer Treat Rep | 1982 | https://conductscience.org/library/papers/6890406 | PubMed |
| 10 | 6537801 | Acute effects of cis-diamminedichloroplatinum (CDDP) on renal function. | Cancer Chemother Pharmacol | 1984 | https://conductscience.org/library/papers/6537801 | PubMed |
| 11 | 4053272 | Nonlinear renal clearance of ultrafilterable platinum in patients treated with cis-dichlorodiammineplatinum (II). | Cancer Chemother Pharmacol | 1985 | https://conductscience.org/library/papers/4053272 | PubMed |
| 12 | 6889863 | The mechanism of renal clearance of cisplatin (cis-dichlorodiammine platinum ii) and its modification by furosemide and probenecid. | Biochem Pharmacol | 1982 | https://conductscience.org/library/papers/6889863 | PubMed |
| 13 | 4039530 | Cisplatin nephrotoxicity. Correlation with plasma platinum concentrations. | Am J Clin Oncol | 1985 | https://conductscience.org/library/papers/4039530 | PubMed |
| 14 | 159127 | Platinate toxicity: past, present, and prospects. | Cancer Treat Rep | 1979 | https://conductscience.org/library/papers/159127 | PubMed |
| 15 | 3891281 | Cisplatin nephrotoxicity: a summary of preventative interventions. | Drug Intell Clin Pharm | 1985 | https://conductscience.org/library/papers/3891281 | PubMed |
| 16 | 4044076 | Model independent pharmacokinetic study of cis-dichlorodiammineplatinum (II). | Int J Clin Pharmacol Ther Toxicol | 1985 | https://conductscience.org/library/papers/4044076 | PubMed |
| 17 | 421230 | Renal excretion kinetics of high-dose cis-dichlorodiammineplatinum(II) administered with hydration and mannitol diuresis. | Cancer Treat Rep | 1979 | https://conductscience.org/library/papers/421230 | PubMed |
| 18 | 6784924 | High-dose cisplatin therapy using mannitol versus furosemide diuresis: comparative pharmacokinetics and toxicity. | Cancer Treat Rep | 1981 | https://conductscience.org/library/papers/6784924 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 28856465 | Guidelines for treatment of renal injury during cancer chemotherapy 2016. | Clin Exp Nephrol | 2018 | https://conductscience.org/library/papers/28856465 | PubMed |
| 8281624 | Combination chemotherapy of human ovarian xenografts with intraperitoneal liposome-incorporated valinomycin and cis-diamminedichloroplatinum(II). | Cancer Chemother Pharmacol | 1994 | https://conductscience.org/library/papers/8281624 | PubMed |
| 2689838 | Drug-induced ototoxicity. Pathogenesis and prevention. | Med Toxicol Adverse Drug Exp | 1989 | https://conductscience.org/library/papers/2689838 | PubMed |
| 2369792 | Influence of hydration on ultrafilterable platinum kinetics and kidney function in patients treated with cis-diamminedichloroplatinum(II). | Cancer Chemother Pharmacol | 1990 | https://conductscience.org/library/papers/2369792 | PubMed |
| 1630874 | Platinum antitumour agents: a review of (bio)analysis. | Pharm Weekbl Sci | 1992 | https://conductscience.org/library/papers/1630874 | PubMed |
| 1394800 | Effect of coadministration of selenite on the toxicity and antitumor activity of cis-diamminedichloroplatinum (II) given repeatedly to mice. | Cancer Chemother Pharmacol | 1992 | https://conductscience.org/library/papers/1394800 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2909288
GET https://conductscience.org/api/papers/v1/2909288/authors